Lipofundin Mct/Lct

Soybean oil, medium-chain triglycerides, the active ingredient in Lipofundin Mct/Lct, is an intravenous lipid emulsion presented as an emulsion for intravenous infusion use. It supplies calories and essential fatty acids to patients requiring parenteral nutrition and helps prevent essential fatty acid deficiency.

GNH USA supplies Lipofundin Mct/Lct as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide, with a focus on quality, regulatory compliance and reliable global distribution to meet the nutritional needs of critically ill patients.

Lipofundin Mct/Lct is used in parenteral nutrition to provide calories and essential fatty acids. - Parenteral nutrition in patients unable to receive enteral feeding: supplies necessary energy and fatty acids when oral or tube feeding is not feasible. - Prevention of essential fatty acid deficiency: delivers linoleic and alpha‑linolenic acids to avoid deficiency during prolonged intravenous feeding. - Support during major surgery or critical illness: provides rapid energy and membrane components to meet increased metabolic demands.

Lipofundin Mct/Lct may be associated with several adverse reactions.

Common Side Effects: - Hypertriglyceridemia: elevated triglyceride levels. - Fever or chills: transient temperature rise during infusion. - Infusion site reactions: erythema, pain or swelling. - Nausea: mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Fat overload syndrome: severe hyperlipidemia with organ dysfunction. - Anaphylactic reaction: sudden severe allergy requiring emergency treatment. - Pulmonary embolism: lipid emboli causing respiratory compromise.

When using Lipofundin Mct/Lct, several precautions should be observed to ensure patient safety. - Monitor triglyceride levels: check serum triglycerides regularly during therapy. - Assess lipid tolerance: discontinue if signs of intolerance such as fever or respiratory distress appear. - Use aseptic technique: maintain sterility of infusion set and catheter. - Avoid in known soy or egg phospholipid allergy: contraindicated in patients with hypersensitivity. - Adjust dose in hepatic impairment: reduce infusion rate in patients with liver dysfunction. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lipofundin Mct/Lct can interact with certain medications, affecting lipid levels or infusion safety.

Major Interactions (Avoid): - Co‑administration with other lipid emulsions: risk of severe hypertriglyceridemia. - Concurrent propofol infusion: additive lipid load may cause fat overload. - High‑dose heparin therapy: may increase triglyceride concentrations.

Moderate Interactions (Monitor Closely): - Corticosteroids: may elevate triglyceride levels, requiring monitoring. - Total parenteral nutrition components: electrolyte and vitamin balance should be reviewed. - Certain antiretroviral agents (e.g., protease inhibitors): can affect lipid metabolism.